InforSense and its partners in SIMDAT, a European Commission-funded grid technology consortium, have completed a pilot project at GlaxoSmithKline to enable virtual drug discovery through virtual outsourcing of data analysis via secure grid technology, InforSense said this week.

The Human Gene Mutation Database (HGMD) is a manually curated, comprehensive collection of disease-causing, germline mutations. Since 1996, a team of experts has manually catalogued over a quarter of a million mutations for the database.